156 related articles for article (PubMed ID: 37903917)
1. Maximizing the success of biosimilar implementation.
Alten R; Weinbrecht-Mischkewitz M
Nat Rev Rheumatol; 2023 Dec; 19(12):757-758. PubMed ID: 37903917
[No Abstract] [Full Text] [Related]
2. The 9
Chu L
Drugs Today (Barc); 2018 Jul; 54(7):445-449. PubMed ID: 30090881
[TBL] [Abstract][Full Text] [Related]
3. New frontiers in oncology: biosimilar monoclonal antibodies for the treatment of breast cancer.
Thill M
Expert Rev Anticancer Ther; 2015 Mar; 15(3):331-8. PubMed ID: 25539719
[TBL] [Abstract][Full Text] [Related]
4. A survey of global biosimilar implementation practice conducted by the International Society of Oncology Pharmacy Practitioners.
Foreman E; Patel H; Siderov J; Harchowal J; Bubalo J; Chan A
J Oncol Pharm Pract; 2020 Apr; 26(3_suppl):22-32. PubMed ID: 32268828
[TBL] [Abstract][Full Text] [Related]
5. Biosimilars in pediatric rheumatology and their introduction into routine care.
Aragon Cuevas O; Hedrich CM
Clin Immunol; 2020 Jul; 216():108447. PubMed ID: 32360950
[TBL] [Abstract][Full Text] [Related]
6. Biosimilar and interchangeable: Inseparable scientific concepts?
de Mora F; Balsa A; Cornide-Santos M; Carrascosa JM; Marsal S; P Gisbert J; Abad MA; F Duarte R; Wiechmann M; Martínez R
Br J Clin Pharmacol; 2019 Nov; 85(11):2460-2463. PubMed ID: 31486117
[No Abstract] [Full Text] [Related]
7. What do oncologists need to know about biosimilar products?
Leung LK; Mok K; Liu C; Chan SL
Chin J Cancer; 2016 Oct; 35(1):91. PubMed ID: 27733189
[TBL] [Abstract][Full Text] [Related]
8. Current Japanese Regulatory Systems for Generics and Biosimilars.
Kuribayashi R; Sawanobori K
J Pharm Sci; 2018 Mar; 107(3):785-787. PubMed ID: 29113922
[TBL] [Abstract][Full Text] [Related]
9. Clinical development and trial design of biosimilar products: a Japanese perspective.
Nagasaki M; Ando Y
J Biopharm Stat; 2014; 24(6):1165-72. PubMed ID: 25033370
[TBL] [Abstract][Full Text] [Related]
10. Biosimilar therapy for inflammatory bowel disease.
Avendaño-Solá C; Panés J; Calvo G
Rev Esp Enferm Dig; 2014 Jan; 106(1):65-6. PubMed ID: 24689722
[No Abstract] [Full Text] [Related]
11. Biosimilar DMARDs: What Does the Future Hold?
Araújo F; Gonçalves J; Fonseca JE
Drugs; 2016 Apr; 76(6):629-37. PubMed ID: 26941025
[TBL] [Abstract][Full Text] [Related]
12. Author´s answer: Biosimilar therapy for inflammatory bowel disease.
Argüelles-Arias F; Barreiro-de-Acosta M; Carballo F; Hinojosa J; Tejerina T
Rev Esp Enferm Dig; 2014 Jan; 106(1):67-8. PubMed ID: 24689723
[No Abstract] [Full Text] [Related]
13. A consensus statement on the use of biosimilar medicines in hematology in Australia.
Gregory GP; Carrington C; Cheah CY; Hawkes EA; Irving IM; Siderov J; Opat S
Asia Pac J Clin Oncol; 2020 Aug; 16(4):211-221. PubMed ID: 32285612
[TBL] [Abstract][Full Text] [Related]
14. European Medicines Agency guidelines to increase the pace of biosimilar development.
Parks L
Bioanalysis; 2012 Nov; 4(22):2665. PubMed ID: 23346558
[No Abstract] [Full Text] [Related]
15. The advent of biosimilar therapies in rheumatology--"O brave new world".
Scheinberg MA; Kay J
Nat Rev Rheumatol; 2012 Jun; 8(7):430-6. PubMed ID: 22664834
[TBL] [Abstract][Full Text] [Related]
16. Biosimilar products are not bioidentical.
Garber AJ
J Diabetes; 2015 Mar; 7(2):153-4. PubMed ID: 25395269
[No Abstract] [Full Text] [Related]
17. Biosimilar medicines used for cancer therapy in Europe: a review.
Santos SB; Sousa Lobo JM; Silva AC
Drug Discov Today; 2019 Jan; 24(1):293-299. PubMed ID: 30244082
[TBL] [Abstract][Full Text] [Related]
18. The use of biosimilar drugs in psoriasis: a position paper.
Carretero Hernández G; Puig L;
Actas Dermosifiliogr; 2015 May; 106(4):249-51. PubMed ID: 25712906
[No Abstract] [Full Text] [Related]
19. Biosimilars: Extrapolation for oncology.
Curigliano G; O'Connor DP; Rosenberg JA; Jacobs I
Crit Rev Oncol Hematol; 2016 Aug; 104():131-7. PubMed ID: 27354233
[TBL] [Abstract][Full Text] [Related]
20. Biosimilar Treatments Have Practice Implications.
Wiley K
ONS Connect; 2016 Apr; 31(4):38. PubMed ID: 27209660
[No Abstract] [Full Text] [Related]
[Next] [New Search]
